関連する実験動画
Updated: Sep 10, 2025
09:15
Induction of Eryptosis in Red Blood Cells Using a Calcium Ionophore
Published on: January 21, 2020
8.9K
肝臓疾患におけるエリプトーシス: 貧血と高血圧への貢献
Saulesh Kurmangaliyeva1, Kristina Baktikulova1, Anton Tkachenko2
1Department of Microbiology, Virology, and Immunology, NJSC "West Kazakhstan Marat Ospanov Medical University", 68 Maresyev st, Aktobe 030000, Kazakhstan.
Medical sciences (Basel, Switzerland)
|August 22, 2025
まとめ
プログラムされた赤血球死亡の形態である加速エリプトーシスは,肝臓疾患における貧血と高血栓化に寄与する. エリプトーシスをターゲットにすることで,これらの状態の治療戦略を提供することができます.
科学分野:
- 細胞生物学
- 血液学
- ヘパトロジー
背景:
- エリプトーシスは,赤血球の制御された細胞死であり,Ca2+の流入とフォスファディルセリンの外部化が含まれています.
- 加速性エリプトーシスは,様々な疾患,特に貧血と関連しており,肝臓病理にますます関与しています.
- エリプトーシスの理解は,肝疾患の病原性における貧血と高血栓の理解に不可欠です.
研究 の 目的:
- エリプトーシスのシグナル伝達経路と生理学的役割を見直す.
- 肝臓疾患と関連する合併症に対するエリプトーシスの影響を総合的に分析する.
- 肝臓疾患におけるエリプトーシスを標的とする潜在的な治療戦略を探求する.
主な方法:
- エリプトーシスと肝臓疾患に関するPubMedインデックス出版物の体系的分析.
- エリプトーシスのシグナル伝達,生理学的役割,疾患関連に関する現在の知識のレビュー.
- 肝疾患でエリプトーシスを誘発する代謝産物および薬物の検査
主要な成果:
- エリプトーシスは貧血,高血圧,肝臓疾患における内皮損傷に寄与する.
- 特定の代謝産物 (ビリルビン,胆酸) と薬剤は肝臓疾患でエリプトーシスを引き起こす可能性があります.
- 薬物誘発性エリプトーシスは,肝疾患患者の治療関連貧血を部分的に説明する可能性がある.
結論:
- エリプトーシスは肝疾患の病原性と合併症において重要な役割を果たします.
- エリプトーシスの抑制は,肝疾患における貧血と血栓の管理のための潜在的な治療法である.
- エリプトーシス調節に関するさらなる研究は,肝臓病変の新たな治療法につながる可能性があります.
関連する概念動画
01:27Disorders of Erythrocytes
1.2K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.2K
01:22Lifecycle of Erythrocytes
2.3K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
2.3K
01:24Factors Affecting Erythropoiesis
3.6K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.6K
01:14Erythropoiesis
4.7K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.7K
01:24Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
01:01Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K